These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 10618553)
21. Single oral immunization with replication deficient recombinant adenovirus elicits long-lived transgene-specific cellular and humoral immune responses. Sharpe S; Fooks A; Lee J; Hayes K; Clegg C; Cranage M Virology; 2002 Feb; 293(2):210-6. PubMed ID: 11886240 [TBL] [Abstract][Full Text] [Related]
22. Induction of specific CD8+ memory T cells and long lasting protection following immunization with Salmonella typhimurium expressing a lymphocytic choriomeningitis MHC class I-restricted epitope. Shams H; Poblete F; Rüssmann H; Galán JE; Donis RO Vaccine; 2001 Nov; 20(3-4):577-85. PubMed ID: 11672924 [TBL] [Abstract][Full Text] [Related]
23. Mucosal priming of simian immunodeficiency virus-specific cytotoxic T-lymphocyte responses in rhesus macaques by the Salmonella type III secretion antigen delivery system. Evans DT; Chen LM; Gillis J; Lin KC; Harty B; Mazzara GP; Donis RO; Mansfield KG; Lifson JD; Desrosiers RC; Galán JE; Johnson RP J Virol; 2003 Feb; 77(4):2400-9. PubMed ID: 12551977 [TBL] [Abstract][Full Text] [Related]
24. Selection of the same major T cell determinants of influenza nucleoprotein after vaccination or exposure to infectious virus. Brett SJ; Gao XM; Liew FY; Tite JP J Immunol; 1991 Sep; 147(5):1647-52. PubMed ID: 1715366 [TBL] [Abstract][Full Text] [Related]
25. VaxCelerate II: rapid development of a self-assembling vaccine for Lassa fever. Leblanc P; Moise L; Luza C; Chantaralawan K; Lezeau L; Yuan J; Field M; Richer D; Boyle C; Martin WD; Fishman JB; Berg EA; Baker D; Zeigler B; Mais DE; Taylor W; Coleman R; Warren HS; Gelfand JA; De Groot AS; Brauns T; Poznansky MC Hum Vaccin Immunother; 2014; 10(10):3022-38. PubMed ID: 25483693 [TBL] [Abstract][Full Text] [Related]
26. Delivery of epitopes by the Salmonella type III secretion system for vaccine development. Rüssmann H; Shams H; Poblete F; Fu Y; Galán JE; Donis RO Science; 1998 Jul; 281(5376):565-8. PubMed ID: 9677200 [TBL] [Abstract][Full Text] [Related]
27. Lassa Virus Vaccine Candidate ML29 Generates Truncated Viral RNAs Which Contribute to Interfering Activity and Attenuation. Johnson DM; Cubitt B; Pfeffer TL; de la Torre JC; Lukashevich IS Viruses; 2021 Jan; 13(2):. PubMed ID: 33573250 [TBL] [Abstract][Full Text] [Related]
28. Development of live-attenuated arenavirus vaccines based on codon deoptimization. Cheng BY; Ortiz-Riaño E; Nogales A; de la Torre JC; Martínez-Sobrido L J Virol; 2015 Apr; 89(7):3523-33. PubMed ID: 25589652 [TBL] [Abstract][Full Text] [Related]
29. Non-neutralizing antibodies elicited by recombinant Lassa-Rabies vaccine are critical for protection against Lassa fever. Abreu-Mota T; Hagen KR; Cooper K; Jahrling PB; Tan G; Wirblich C; Johnson RF; Schnell MJ Nat Commun; 2018 Oct; 9(1):4223. PubMed ID: 30310067 [TBL] [Abstract][Full Text] [Related]